Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Sagility India IPO
Price Band
₹28.0–30.0
Issue Size
₹2106.4 Cr
Lot Size
500 shares
Min Investment
₹15,000
GMP
+₹0.3 (1.0%)
Issue Price
₹30.0
Subject to Sauda
₹100
Paid only if allotted
Sagility India IPO AI Summary
- Sagility India IPO is listed on BSE, NSE in the IT Enabled Services sector.
- Price band: ₹28.0–₹30.0 per share, lot size 500 shares (min. investment ₹15,000).
- Subscription window: 05 Nov–07 Nov 2024, listing on 12 Nov 2024.
- Current GMP is +₹0.3 (1.0%), an estimated listing price of ₹30 — unofficial and can change daily.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Sagility India IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 07 Nov 2024 — not a current signal.
8 of 11 reviewers say Positive
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Sagility India IPO Grey Market Premium (GMP) Today
GMP
+₹0.3
GMP %
+1.0%
Est. Listing
₹30.3
Updated: 25 Jul 2026 14:03
About the Company
Sagility India Limited, formerly known as Berkmeer India Private Limited, provides healthcare-focused solutions and services to Payers (US health insurers who fund and reimburse the cost of healthcare services) and Providers (primarily hospitals, physicians, diagnostics and medical technology companies). The company supports the core business of both payers and providers. Services to payers span their entire operational spectrum, including centralized claims administration and clinical services functions. These include claims administration, payment integrity, clinical management and other services. For providers, the company offers revenue cycle management services to assist them in managing their billing and claiming treatment costs from payers. In addition, the Company also offers some of the services it provides to Payers to Pharmacy Benefit Managers (“PBMs”) who manage prescription drug coverage for members (i.e., insureds) under health benefit plans. The company's customers are all based in the USA. As of March 31, 2024, the Company's five largest customer groups (i.e. the customer companies together with their subsidiaries) had an average tenure of service of 17 years. In January 2024, the company served five of the ten largest payers in the US (source: Everest Report). In addition, the company acquired 20 new customers in the financial years 2024 and 2023. As of March 31, 2024, Sagility India had 35,044 employees, of which 60.52% were women. As of March 31, 2024, 1,687 of the employees held certifications, including 374 certified medical coders, 1,280 registered nurses in the US, Philippines and India, and 33 employees with other degrees such as dentistry, surgery and pharmacy.
Company Financials (₹ Cr)
As of 2024-03-31
| Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 10,388.01 | 10,664.20 | 10,590.48 | 10,096.28 |
| Total Income | 1,247.76 | 4,781.50 | 4,236.06 | 944.39 |
| Profit After Tax | 22.29 | 228.27 | 143.57 | -4.67 |
| NET Worth | 7,608.16 | 6,443.13 | 6,206.67 | 4,026.62 |
| Reserves and Surplus | 2,704.28 | 1,855.44 | 4,013.38 | 2,073.80 |
| Total Borrowing | 943.91 | 1,933.52 | 2,347.94 | 4,239.23 |
Key Ratios
EPS
₹0.49
NAV
₹16.25
RoNW
0.29%
P/B Value
2.00
P/E Ratio
61.52
Market Cap
₹14043.99 Cr
PAT Margin
11.83%
Debt/Equity
0.15
Peer Comparison
| Company | NAV |
|---|---|
| Sagility India Limited This IPO | 15.03 |
Promoters
Sagility Holdings BV and Sagility BV
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 The Company will not receive any proceeds from the Offer. For details of Offered Shares from the Promoter Selling Shareholder.
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹944.39 Cr in the period ending March 31, 2022, rising to ₹4,236.06 Cr by March 31, 2023, and further increasing to ₹4,781.50 Cr by March 31, 2024. However, the most recent figure of ₹1,247.76 Cr for the period ending June 30, 2024, though significant, is only a 9-month figure and not directly comparable to the full fiscal years.
Profit Trend
Profit After Tax was a loss of ₹4.67 Cr in the period ending March 31, 2022, which improved to ₹143.57 Cr by March 31, 2023. This further increased to ₹228.27 Cr by March 31, 2024. The latest figure of ₹22.29 Cr for the period ending June 30, 2024, while positive, is not directly comparable as it represents only a 9-month period.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected premium or discount at which shares of an IPO are likely to trade in the unofficial market before they are listed on the stock exchange. A positive GMP suggests that investors expect the stock to list at a price higher than the issue price, while a negative GMP indicates the opposite.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy and risk tolerance. It is important to consider the company's fundamentals, market position, and potential for growth.
Who May Want to Wait
Investors who prefer stable, low-risk investments may want to avoid IPOs like this, which can exhibit significant price fluctuations in the short term. Those with a low risk tolerance should carefully evaluate their investment goals before considering participation.
Listing Gains — The Risk
Listing-day gains are not guaranteed and can be influenced by various factors, including market conditions, investor sentiment, and overall demand for the stock. Investors should be aware that while some IPOs may experience a surge in price on their debut, others may not perform as expected, leading to potential losses.
This evaluation is generated from Sagility India's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Sagility India IPO GMP today?
Sagility India IPO GMP today is +₹0.3 (1.0%), indicating an estimated listing price of ₹30. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Sagility India IPO?
The price band of Sagility India IPO is ₹28.0–₹30.0 per share.
When does Sagility India IPO open and close?
Sagility India IPO opens on 05 November 2024 and closes on 07 November 2024.
When does Sagility India IPO list on the stock exchange?
Sagility India IPO listed on 12 November 2024 at ₹30.3.
What is the lot size for Sagility India IPO?
The lot size for Sagility India IPO is 500 shares, requiring a minimum investment of ₹15,000.
What is the price band for the Sagility India IPO?
The price band for the Sagility India IPO is between ₹28.0 and ₹30.0.
What is the minimum investment required for this IPO?
The minimum investment required for this IPO is ₹15,000.
What is the lot size for the Sagility India IPO?
The lot size for the Sagility India IPO is 500 shares.
When does the Sagility India IPO open and close?
The Sagility India IPO opens on November 5, 2024, and closes on November 7, 2024.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected premium or discount at which shares of an IPO are likely to trade in the unofficial market before listing.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
05 Nov 2024
Close
07 Nov 2024
Allotment
08 Nov 2024
Listing
12 Nov 2024
Similar IPOs in IT Enabled Services
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Sagility India?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.